Funding, News and Announcements

» Go to news main

United States Department of Defense

Posted by Jaq-Lin Larder on February 21, 2022 in Announcements

This message is to notify the research community of recently released Fiscal Year 2022 pre-announcements for the Department of Defense (DoD) programs managed by the office of Congressionally Directed Medical Research Programs (CDMRP). CDMRP understands that applicants are impacted by COVID-19. Submission deadlines for pre-applications and full applications will incorporate the maximum time that is feasible for each FY22 program. Thank you for your efforts during this challenging time.

FY22 Pre-announcements released:

Orthotics and Prosthetics Outcomes Research Program (OPORP)

  • Clinical Research Award
  • Clinical Trial Award

Peer Reviewed Orthopaedic Research Program (PRORP)

  • Applied Research Award
  • Clinical Translational Research Award
  • Clinical Trial Award
  • New: Additional resources and information regarding the outcomes of the 2021 PRORP Stakeholders Meeting can be found on the PRORP webpage.

Spinal Cord Injury Research Program (SCIRP)

  • Clinical Trial Award
  • Translational Research Award
  • Investigator-Initiated Research Award

A pre-application is required and must be submitted through the electronic Biomedical Research Application Portal (eBRAP) prior to the pre-application deadline. All applications must conform to the final Funding Opportunities/Program Announcements and General Application Instructions which can be found on the website. A listing of all CDMRP and other USAMRDC extramural funding opportunities can be obtained on the website by performing a basic search using CFDA Number 12.420.

For email notification when CDMRP funding opportunities are released, subscribe to program-specific news and updates under “Email Subscriptions” on the eBRAP homepage. For more information about the CDMRP-administered programs, please visit the CDMRP website.

For more information on types of funding opportunities offered and application strategies review the CDMRP Webinar Series.

Contact Details

Questions may be addressed to